Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 20 Issue 1, January 2020

Volume 20 Issue 1

Bringing the brain into focus, inspired by this month’s Focus issue.

Cover design: Lara Crow.


Research Highlights

  • Research Highlight |

    Strickley, Messerschmidt et al. show that beta human papilloma virus (β-HPV) infection itself is not causal in cutaneous squamous cell carcinoma (SCC) development in the context of immunosuppression — instead, the loss of β-HPV-mediated T cell immunity promotes SCC.

    • Ulrike Harjes
  • Research Highlight |

    Two papers report the discovery and preclinical analyses of two different covalent inhibitors of KRAS-G12C (AMG 510 and MRTX849) as well as the first data on the efficacy of these inhibitors in cancer patients.

    • Sarah Seton-Rogers


  • Viewpoint |

    In this Viewpoint article, we asked four experts to provide their opinions on important aspects of brain metastasis biology, focusing on the unique microenvironment and therapeutic targets in the brain, preclinical models and how studying brain metastases could inform primary brain tumour biology.

    • Adrienne Boire
    • , Priscilla K. Brastianos
    •  & Manuel Valiente



  • Review Article |

    This Review discusses how advances in our understanding of the immune system within the brain have implications for the successful implementation of immunotherapy to treat brain tumours, despite challenges such as effective delivery, target specificity and intratumour heterogeneity.

    • John H. Sampson
    • , Michael D. Gunn
    •  & David M. Ashley


  • Review Article |

    This Review discusses recent genomic, epigenomic, transcriptomic and proteomic profiling studies of human medulloblastoma that have advanced our understanding of its disease subgroups. These efforts have provided new insights into the diverse biology of medulloblastomas that will hopefully lead to improved diagnosis and therapy.

    • Volker Hovestadt
    • , Olivier Ayrault
    •  & Paul A. Northcott



Quick links